NASDAQ: SAVA
Cassava Sciences Inc Stock Ownership - Who owns Cassava Sciences?

Insider buying vs selling

Have Cassava Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James William KupiecChief Medical Officer2024-11-294,000$3.87
$15.48kSell
Eric SchoenChief Financial Officer2024-11-2959,800$3.86
$230.83kSell
Eric SchoenChief Financial Officer2024-11-292,000$3.82
$7.64kSell
Eric SchoenChief Financial Officer2024-11-2950,000$1.18
$59.00kBuy

1 of 1

SAVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SAVA insiders and whales buy or sell their stock.

SAVA Shareholders

What type of owners hold Cassava Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eastbourne Capital Management LLC29.25%14,131,378$33.63MInsider
Remi Barbier18.27%8,827,362$21.01MInsider
Sabretooth Master Fund LP8.82%4,263,076$10.15MInsider
Black Bear Offshore Master Fund LP8.67%4,186,238$9.96MInsider
Blackrock Inc7.19%3,474,980$8.27MInstitution
Vanguard Group Inc5.06%2,442,307$5.81MInstitution
Armistice Capital LLC3.42%1,651,340$3.93MInsider
Sanford Robertson2.35%1,135,851$2.70MInsider
Geode Capital Management LLC2.13%1,026,599$2.44MInstitution
Two Sigma Advisers LP1.88%908,600$2.16MInstitution

1 of 3

SAVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SAVA31.06%68.94%Net Selling
COYA27.88%12.80%Net Buying
MCRB47.82%52.18%Net SellingNet Selling
HLVX61.01%38.99%Net Selling
PPBT0.01%0.00%

Cassava Sciences Stock Ownership FAQ

Who owns Cassava Sciences?

Cassava Sciences (NASDAQ: SAVA) is owned by 32.74% institutional shareholders, 72.66% Cassava Sciences insiders, and 0.00% retail investors. Eastbourne Capital Management LLC is the largest individual Cassava Sciences shareholder, owning 14.13M shares representing 29.25% of the company. Eastbourne Capital Management LLC's Cassava Sciences shares are currently valued at $31.23M.

If you're new to stock investing, here's how to buy Cassava Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.